Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Has Vita Coco Company (COCO) Outpaced Other Consumer Staples Stocks This Year?
Has Vita Coco Company (COCO) Outpaced Other Consumer Staples Stocks This Year?

For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Vita Coco Company, Inc. (COCO) been one of those

Here's Why Newmont Corporation (NEM) is a Strong Value Stock
Here's Why Newmont Corporation (NEM) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now?
Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Are Business Services Stocks Lagging  Mastercard (MA) This Year?
Are Business Services Stocks Lagging Mastercard (MA) This Year?

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has MasterCard (MA) been one of those stocks this

Are Investors Undervaluing Noah Holdings (NOAH) Right Now?
Are Investors Undervaluing Noah Holdings (NOAH) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Are Transportation Stocks Lagging  Aercap (AER) This Year?
Are Transportation Stocks Lagging Aercap (AER) This Year?

For those looking to find strong Transportation stocks, it is prudent to search for companies in the group that are outperforming their peers. Is AerCap (AER) one of those stocks right now? A quick

Here's Why Coterra Energy (CTRA) is a Strong Value Stock
Here's Why Coterra Energy (CTRA) is a Strong Value Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Is TDK (TTDKY) a Great Value Stock Right Now?
Is TDK (TTDKY) a Great Value Stock Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Is Telenor (TELNY) Outperforming Other Utilities Stocks This Year?
Is Telenor (TELNY) Outperforming Other Utilities Stocks This Year?

Investors interested in Utilities stocks should always be looking to find the best-performing companies in the group. Is Telenor ASA (TELNY) one of those stocks right now? Let's take a closer look

Here's Why BJ's Wholesale Club (BJ) is a Strong Value Stock
Here's Why BJ's Wholesale Club (BJ) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Should Value Investors Buy Mitsubishi (MSBHF) Stock?
Should Value Investors Buy Mitsubishi (MSBHF) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II diabetes (T2D) and Wegovy for obesity. Ozempic and Wegovy include the same

The Zacks Analyst Blog Highlights Alphabet and Apple
The Zacks Analyst Blog Highlights Alphabet and Apple

For Immediate Release

Chicago, IL – July 18, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Omnicom Group Stock Barely Moves Since Q2 Earnings Beat
Omnicom Group Stock Barely Moves Since Q2 Earnings Beat

Omnicom Group Inc. OMC reported impressive second-quarter 2025 results, wherein both earnings and revenues beat the Zacks Consensus Estimate but failed to impress the market.

The stock has barely

Down 9.0% in 4 Weeks, Here's Why Abbott (ABT) Looks Ripe for a Turnaround
Down 9.0% in 4 Weeks, Here's Why Abbott (ABT) Looks Ripe for a Turnaround

Abbott (ABT) has been on a downward spiral lately with significant selling pressure. After declining 9% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in

Down 10.0% in 4 Weeks, Here's Why New Gold (NGD) Looks Ripe for a Turnaround
Down 10.0% in 4 Weeks, Here's Why New Gold (NGD) Looks Ripe for a Turnaround

New Gold (NGD) has been beaten down lately with too much selling pressure. While the stock has lost 10% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Zacks Industry Outlook Highlights Alliance Resource Partners and SunCoke Energy
Zacks Industry Outlook Highlights Alliance Resource Partners and SunCoke Energy

For Immediate Release

Chicago, IL – July 18, 2025 – Today, Zacks Equity Research discusses Alliance Resource Partners ARLP and SunCoke Energy SXC.

Industry: Coal

Link: https://www.zacks.com/commenta

Chipotle to Report Q2 Earnings: What Lies Ahead for the Stock?
Chipotle to Report Q2 Earnings: What Lies Ahead for the Stock?

Chipotle Mexican Grill, Inc. CMG is scheduled to report its second-quarter 2025 results after the closing bell on July 23, 2025.In the last reported quarter, the company’s earnings beat the Zacks

Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

OneSpan (OSPN) Is Considered a Good Investment by Brokers: Is That True?
OneSpan (OSPN) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Why This 1 Computer and Technology Stock Could Be a Great Addition to Your Portfolio
Why This 1 Computer and Technology Stock Could Be a Great Addition to Your Portfolio

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Compared to Estimates, Autoliv (ALV) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Autoliv (ALV) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Autoliv, Inc. (ALV) reported revenue of $2.71 billion, up 4.2% over the same period last year. EPS came in at $2.21, compared to $1.87 in the year-ago quarter.

The

Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet
Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Ally Financial (ALLY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Ally Financial (ALLY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Ally Financial (ALLY) reported $2.08 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 4.1%. EPS of $0.99 for the same period compares to $0.97 a year

Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)